Spanish Registry of Esophagogastric Cancer (AGAMENON)

Fundación Sociedad Española de Oncologia Médica

Status

Enrolling

Conditions

Gastric Cancer

Esophageal Cancer

Treatments

Procedure: Surgery

Drug: Chemotherapy, anti-targeted agents and immunotherapy

Radiation: Radiotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT04958720

RXSCXJ3E6E (Other Identifier)

2020-01

Details and patient eligibility

About

This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach cancer in order to optimize the management, treatment and evolution of patients, the possibility of comparing variables with those of other series or groups, and promotes the quality of scientific publications.

Full description

Patient data will be collected from medical records retrospectively.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown).
Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause.

Exclusion criteria